Thuja Capital Management (“Thuja Capital”) is an independent venture capital management firm specialized in investing in early-stage medical product companies in the Netherlands and Belgium. With our office in Utrecht Science Park, close to Utrecht University and University Medical Center Utrecht, we are conveniently located in the heart of the Netherlands, at a one-hour driving distance from Belgium.
Healthcare spending has been rising steadily over the last decades, and is expected to continue to grow, due to increased access to healthcare in the developing countries, the aging population and novel technologies. Although the progress in medicine has been phenomenal during the last century, there are still a large number of unmet medical needs.
The Benelux region is at the forefront of life sciences research, yet conversion into medical products has been lagging behind. It is the ambition of Thuja Capital to leverage good science with entrepreneurship and capital, in order to accelerate innovative, affordable medical products to patients, thus pairing societal return to attractive financial reward for its shareholders.
The team of Thuja Capital has a long-standing and successful track record in investments in, and management of, medical product companies.
Thuja Capital takes a unique position: it is the only independent medical product VC with an investment focus on the Benelux. Moreover, we are among the declining number of VCs that invest at a truly early stage.
In addition to capital investments we leverage our extensive network, advisory board and our own experience to help and turn good science into valuable innovative medical products. We believe that we should work closely with our portfolio companies and provide hands-on support. By taking an active role, Thuja Capital aims to help these companies to strengthen and grow their businesses. The central location of our office warrants that we are always within short travelling distance.